Valuation: Isodiol International Inc.

Market Cap 39.11L 27.9L 24.95L 23.08L 20.9L 27Cr 39.75L 2.78Cr 1.1Cr 14Cr 1.05Cr 1.02Cr 44Cr P/E 2018
-4.94x
P/E 2019 -0.37x
Enterprise Value 91.33L 65.15L 58.26L 53.9L 48.8L 62Cr 92.83L 6.49Cr 2.57Cr 32Cr 2.45Cr 2.39Cr 102.65Cr EV / Sales 2018
12.6x
EV / Sales 2019 2.48x
Free-Float
100%
Yield 2018 *
-
Yield 2019 -
1 month 0
Extreme 1.0E-6
0
Current year 0
Extreme 1.0E-6
0
1 year 0
Extreme 1.0E-6
0
3 years 0
Extreme 1.0E-6
0
5 years 0
Extreme 1.0E-6
0.02
10 years 0
Extreme 1.0E-6
16.9
Manager TitleAgeSince
Chief Executive Officer - 24/05/2017
Corporate Officer/Principal - 30/08/2018
Director TitleAgeSince
Director/Board Member - 24/05/2017
Director/Board Member - 30/08/2018
Director/Board Member - 21/11/2018
Change 5-day change 1-year change 3-year change Capi.($)
0.00%0.00% - - 128
+0.45%+3.13%+54.96%+125.16% 1,14000Cr
+0.94%+4.93%+39.86%+78.72% 64TCr
+0.39%+1.44%+25.77%+97.48% 51TCr
-0.01%+1.62%+48.17%+66.65% 38TCr
-3.21%-2.10%+60.72%+33.22% 35TCr
+1.44%+2.40%+25.57%+54.66% 29TCr
-0.02%+1.87%+2.45%+26.97% 27TCr
+1.22%+4.63%+52.40%+64.85% 24TCr
+1.70%+3.67%+31.21%+102.15% 20TCr
Average +0.33%+2.63%+37.90%+72.21% 40.14TCr
Weighted average by Cap. +0.15%+2.98%+41.77%+84.33%

Financials

2018 2019
Net sales 1.91Cr 1.37Cr 1.22Cr 1.13Cr 1.02Cr 129.87Cr 1.95Cr 14Cr 5.38Cr 68Cr 5.12Cr 5.01Cr 215.08Cr 2.22Cr 1.59Cr 1.42Cr 1.31Cr 1.19Cr 150.98Cr 2.26Cr 16Cr 6.25Cr 79Cr 5.96Cr 5.83Cr 250.04Cr
Net income -3.6Cr -2.57Cr -2.3Cr -2.13Cr -1.92Cr -244.45Cr -3.66Cr -26Cr -10Cr -127.86Cr -9.64Cr -9.44Cr -404.83Cr -13Cr -8.98Cr -8.03Cr -7.43Cr -6.73Cr -854.5Cr -13Cr -89Cr -35Cr -446.93Cr -34Cr -33Cr -1.42TCr
Net Debt -1.55Cr -1.11Cr -99.18L -91.76L -83.08L -105.53Cr -1.58Cr -11Cr -4.37Cr -55Cr -4.16Cr -4.07Cr -174.76Cr 52.22L 37.25L 33.31L 30.82L 27.9L 35Cr 53.08L 3.71Cr 1.47Cr 19Cr 1.4Cr 1.37Cr 59Cr
Logo Isodiol International Inc.
Isodiol International Inc. is a Canada-based company, which is engaged in product development, sales, marketing, and distribution of hemp-based consumer packaged goods (CPG) and solutions. The Company supplies industrial hemp derivatives for medicinal formulations in the nutraceutical, cosmetic, and pharmaceutical markets. It grows and harvests hemp on an industrial scale, then processes and extracts cannabidiol (CBD) for distribution. It has commercialized naturally isolated CBD, including micro-encapsulations, and nanotechnology for consumables and topical skin care products. The Company's ready to label program offers a range of CBD products ready to be added or developed for various brands. The Company is focused on developing over-the-counter and pharmaceutical drugs and international expansion into Latin America, Asia, and Europe.
Employees
-
Date Price Change Volume
  1. Stock Market
  2. Stocks
  3. ISOLF Stock